Ulcer disease of the upper gastrointestinal tract.
D000535:Aluminum / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D002927:Cimetidine / Q000009:adverse effects / Q000627:therapeutic use; D004381:Duodenal Ulcer / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D005743:Gastrectomy; D005744:Gastric Acid / Q000378:metabolism; D005755:Gastrins / Q000378:metabolism; D005768:Gastrointestinal Hormones / Q000378:metabolism; D005769:Gastrointestinal Motility; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D007408:Intestinal Absorption; D008787:Metoclopramide / Q000627:therapeutic use; D009093:Mucus / Q000378:metabolism; D010276:Parasympatholytics / Q000627:therapeutic use; D011899:Ranitidine / Q000627:therapeutic use; D012907:Smoking; D013276:Stomach Ulcer / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D013392:Sucralfate; D014628:Vagotomy
D000863:Antacids; D000897:Anti-Ulcer Agents; D005755:Gastrins; D005768:Gastrointestinal Hormones; D006635:Histamine H2 Antagonists; D010276:Parasympatholytics; D013392:Sucralfate; D002927:Cimetidine; D011899:Ranitidine; D000535:Aluminum; D008787:Metoclopramide